<b>Methods</b>: Glypican-3 (GPC3)-specific chimeric antigen receptor (CAR) T-cell cytotoxicity assays were performed to assess the impact of DUSP4 on HCC immune susceptibility. Here, DUSP4 is linked to hepatocellular carcinoma.